Add the specialty areas of your choice to tailor to your professional interests.
Save & Create free account
No thanks, just apply selection
I already have an account. Login

User login

We offer our registered users tailored information, free online courses and exclusive content.

Can't find your password?
Reset it here.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Intrathecal Treatment - Immunological players and evidence of effectiveness

Intrathecal Treatment - Immunological players and evidence of effectiveness
  • Neurology


29 November 2018

This online course prepared by Thomas Müller, MD, focuses on intrathecal immunological players and effectiveness of intrathecal treatments in MS. Professor Müller provides an overview of the main immunologic factors and mechanisms of inflammation in MS and current treatment options. He compares the various serum and cerebrospinal fluid biomarkers of central nervous system inflammation and brain damage. He then looks at the mechanisms of action and efficacy of intrathecal-administered drugs.


By the end of this course participants will:

  • Be able to describe the principal immunological players of intrathecal inflammation.
  • Understand the value and limitations of present serum and CSF biomarkers of CNS inflammation and brain damage.
  • Have a better understanding of the current armamentarium of intrathecal-administered drugs.